LGND

Ligand Pharmaceuticals Incorporated $284.47 1M -3.0% 3M +11.7% YTD +49.6% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.4%
Next 1 week
-0.2%
Next 1 month
-0.8%
Seasonality
Mildly negative window
Next 30 days (to Oct 14): -1.5% median, 45% of the last 33 years finished up.
20-year seasonality chart →
Mean reversion
Oversold — RSI(2) at 18
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.30%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.80 -0.1% · Seasonal tilt -0.7%
$54M/day volume 36% volatility +71% 1-year -13% from ATH
52-week range · 74% of the way up · -13% from the high
$161.82$326.63

Congressional trades in LGND Full tracker →

3 members · 6 buys / 1 sells · $7K–$105K disclosed · latest filing Jun 8, 2026.

BUY GC Gilbert Cisneros · traded May 29, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Mar 3, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Jan 5, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Jan 15, 2026 $1K–$15K
SELL KC Katherine M. Clark · traded Oct 22, 2020 $1K–$15K
BUY KC Katherine M. Clark · traded Apr 3, 2020 $1K–$15K
BUY LS Lamar Smith · traded Dec 1, 2017 $1K–$15K

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 52 days) · EPS est. 2.30.

1-day std dev
6.2%
Finished up
58%
Biggest pop
+19.9%
Biggest drop
-11.4%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.